

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.31445480 |
| 2 | T cell migration (GO:0072678) | 4.16213919 |
| 3 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.03886795 |
| 4 | positive regulation of tolerance induction (GO:0002645) | 4.03229073 |
| 5 | interferon-gamma production (GO:0032609) | 4.02723478 |
| 6 | DNA deamination (GO:0045006) | 3.97446242 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 3.97153181 |
| 8 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.88298920 |
| 9 | positive T cell selection (GO:0043368) | 3.83869380 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 3.66050736 |
| 11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.63540360 |
| 12 | cytidine metabolic process (GO:0046087) | 3.61180441 |
| 13 | cytidine catabolic process (GO:0006216) | 3.61180441 |
| 14 | cytidine deamination (GO:0009972) | 3.61180441 |
| 15 | negative T cell selection (GO:0043383) | 3.53319819 |
| 16 | regulation of T cell tolerance induction (GO:0002664) | 3.51183707 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50402981 |
| 18 | negative regulation of viral genome replication (GO:0045071) | 3.49805038 |
| 19 | response to type I interferon (GO:0034340) | 3.46129195 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.44474667 |
| 21 | positive regulation of defense response to virus by host (GO:0002230) | 3.35766350 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.35642340 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.34427682 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.34427682 |
| 25 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.32925870 |
| 26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.31757288 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.30994208 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.24451261 |
| 29 | leukocyte aggregation (GO:0070486) | 3.23364722 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.23228571 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.22346499 |
| 32 | regulation of tolerance induction (GO:0002643) | 3.22230802 |
| 33 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.19433032 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.19336150 |
| 35 | actin nucleation (GO:0045010) | 3.12421623 |
| 36 | negative regulation of T cell apoptotic process (GO:0070233) | 3.09268742 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.08618375 |
| 38 | detection of other organism (GO:0098543) | 3.08227519 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 3.06987076 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.06765371 |
| 41 | T cell selection (GO:0045058) | 3.06063206 |
| 42 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.05997056 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02884854 |
| 44 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.01932089 |
| 45 | B cell mediated immunity (GO:0019724) | 2.99922848 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99607665 |
| 47 | T-helper 1 type immune response (GO:0042088) | 2.95226589 |
| 48 | cellular response to ethanol (GO:0071361) | 2.94871766 |
| 49 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.94558916 |
| 50 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94313515 |
| 51 | regulation of antigen processing and presentation (GO:0002577) | 2.92968648 |
| 52 | germinal center formation (GO:0002467) | 2.92475531 |
| 53 | positive regulation of interleukin-2 production (GO:0032743) | 2.91020201 |
| 54 | positive regulation of interleukin-1 production (GO:0032732) | 2.89761943 |
| 55 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.89455736 |
| 56 | thymic T cell selection (GO:0045061) | 2.88567692 |
| 57 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.87960981 |
| 58 | positive regulation of interferon-alpha production (GO:0032727) | 2.87692107 |
| 59 | detection of external biotic stimulus (GO:0098581) | 2.86668029 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 2.86574013 |
| 61 | positive regulation of granulocyte differentiation (GO:0030854) | 2.83951733 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79560517 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79560517 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 2.79560517 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79560517 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 2.79560517 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79560517 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.78973683 |
| 69 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.78069769 |
| 70 | regulation of B cell differentiation (GO:0045577) | 2.76571084 |
| 71 | defense response to virus (GO:0051607) | 2.76562832 |
| 72 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.76194616 |
| 73 | regulation of defense response to virus by host (GO:0050691) | 2.75852658 |
| 74 | response to interferon-alpha (GO:0035455) | 2.75625619 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.73049435 |
| 76 | lymphocyte chemotaxis (GO:0048247) | 2.72526321 |
| 77 | defense response to protozoan (GO:0042832) | 2.72062484 |
| 78 | positive regulation of B cell proliferation (GO:0030890) | 2.71989043 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71514175 |
| 80 | response to peptidoglycan (GO:0032494) | 2.70249316 |
| 81 | neutrophil activation involved in immune response (GO:0002283) | 2.69721716 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68800356 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.67183261 |
| 84 | microglial cell activation (GO:0001774) | 2.66970931 |
| 85 | positive regulation of developmental pigmentation (GO:0048087) | 2.66848733 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.66584992 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.66523896 |
| 88 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.65343770 |
| 89 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.65257185 |
| 90 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.64538544 |
| 91 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.64538544 |
| 92 | interferon-gamma secretion (GO:0072643) | 2.62717443 |
| 93 | cellular response to interleukin-15 (GO:0071350) | 2.61419041 |
| 94 | negative regulation of defense response to virus (GO:0050687) | 2.60815437 |
| 95 | establishment of protein localization to Golgi (GO:0072600) | 2.60088576 |
| 96 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59610304 |
| 97 | negative regulation of cell killing (GO:0031342) | 2.59610304 |
| 98 | regulation of viral genome replication (GO:0045069) | 2.58247725 |
| 99 | amine catabolic process (GO:0009310) | 2.55247987 |
| 100 | cellular biogenic amine catabolic process (GO:0042402) | 2.55247987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.50681092 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.86547277 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.71352013 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.23580964 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.06647761 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.05427522 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.79860734 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.48845049 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76996951 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65309953 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63495672 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43210882 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.27107422 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25079553 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02613781 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99660706 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96692895 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96659010 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96551366 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 1.95303368 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.88458718 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.82844198 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.82237141 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78325481 |
| 25 | GATA3_26560356_Chip-Seq_TH2_Human | 1.71355318 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 1.65014912 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58717215 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53776085 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48548278 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48450789 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48144945 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47832421 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46807470 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44512938 |
| 35 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43316045 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39562341 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39486389 |
| 38 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39047945 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36107880 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32332062 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31951986 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31365883 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29418540 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26673008 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24209212 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19554367 |
| 47 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19342023 |
| 48 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.18689897 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16667572 |
| 50 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15161926 |
| 51 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09131789 |
| 52 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08080456 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07305598 |
| 54 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06238986 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02919793 |
| 56 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01780536 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.01698845 |
| 58 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00687974 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00351930 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00232823 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98953031 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98482039 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96995779 |
| 64 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95881740 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95666970 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95341663 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95245729 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.93927160 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 0.93907999 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92809668 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92633550 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91063114 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89960766 |
| 74 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89308733 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88840251 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88466247 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88466247 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87841669 |
| 79 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87325688 |
| 80 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87250606 |
| 81 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86867340 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86755256 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83702119 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83639105 |
| 85 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82894317 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82831796 |
| 87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82792630 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82124555 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82063445 |
| 90 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81548120 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81029104 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80657953 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79891621 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.79140186 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.78574236 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.77251955 |
| 97 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.76900410 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 0.76223698 |
| 99 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76143338 |
| 100 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.76101589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.05680860 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.06939354 |
| 3 | MP0003724_increased_susceptibility_to | 3.55471181 |
| 4 | MP0006054_spinal_hemorrhage | 3.36918231 |
| 5 | MP0005671_abnormal_response_to | 3.22683369 |
| 6 | MP0009785_altered_susceptibility_to | 2.97660598 |
| 7 | MP0000015_abnormal_ear_pigmentation | 2.68127384 |
| 8 | MP0006082_CNS_inflammation | 2.50978270 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.50147054 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.47406736 |
| 11 | MP0004381_abnormal_hair_follicle | 2.45804581 |
| 12 | MP0001800_abnormal_humoral_immune | 2.44874902 |
| 13 | MP0005387_immune_system_phenotype | 2.33183210 |
| 14 | MP0001790_abnormal_immune_system | 2.33183210 |
| 15 | MP0009764_decreased_sensitivity_to | 2.31914316 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.29767555 |
| 17 | MP0002419_abnormal_innate_immunity | 2.29480606 |
| 18 | MP0005025_abnormal_response_to | 2.29029590 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.16899727 |
| 20 | MP0002723_abnormal_immune_serum | 2.16811467 |
| 21 | MP0003136_yellow_coat_color | 2.16188187 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.04407215 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.02360916 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.02224624 |
| 25 | MP0001819_abnormal_immune_cell | 2.00182750 |
| 26 | MP0000685_abnormal_immune_system | 1.98158906 |
| 27 | MP0003436_decreased_susceptibility_to | 1.96882217 |
| 28 | MP0002332_abnormal_exercise_endurance | 1.91440548 |
| 29 | MP0002405_respiratory_system_inflammati | 1.86364098 |
| 30 | MP0004947_skin_inflammation | 1.75859814 |
| 31 | MP0003045_fibrosis | 1.72660334 |
| 32 | MP0003303_peritoneal_inflammation | 1.71258541 |
| 33 | MP0005310_abnormal_salivary_gland | 1.69971960 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.64579932 |
| 35 | MP0003195_calcinosis | 1.51597280 |
| 36 | MP0000716_abnormal_immune_system | 1.47689984 |
| 37 | MP0002095_abnormal_skin_pigmentation | 1.46939239 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.41126569 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.40707037 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.40322062 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.36961332 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.35963088 |
| 43 | MP0002398_abnormal_bone_marrow | 1.34696326 |
| 44 | MP0003448_altered_tumor_morphology | 1.34392714 |
| 45 | MP0008260_abnormal_autophagy | 1.33167271 |
| 46 | MP0002722_abnormal_immune_system | 1.30336401 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.28738322 |
| 48 | MP0002736_abnormal_nociception_after | 1.24717323 |
| 49 | MP0003866_abnormal_defecation | 1.24115531 |
| 50 | MP0008004_abnormal_stomach_pH | 1.23939716 |
| 51 | MP0005083_abnormal_biliary_tract | 1.23701829 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.20992436 |
| 53 | MP0005409_darkened_coat_color | 1.19000374 |
| 54 | MP0003690_abnormal_glial_cell | 1.14699779 |
| 55 | MP0008469_abnormal_protein_level | 1.12192456 |
| 56 | MP0000858_altered_metastatic_potential | 1.10660577 |
| 57 | MP0003075_altered_response_to | 1.09189362 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.07608039 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.06288278 |
| 60 | MP0002429_abnormal_blood_cell | 1.05756532 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.04088231 |
| 62 | MP0001853_heart_inflammation | 1.03701561 |
| 63 | MP0005166_decreased_susceptibility_to | 1.01464808 |
| 64 | MP0009763_increased_sensitivity_to | 1.00874756 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.99097137 |
| 66 | MP0000371_diluted_coat_color | 0.97181560 |
| 67 | MP0002006_tumorigenesis | 0.96836352 |
| 68 | MP0002168_other_aberrant_phenotype | 0.96365075 |
| 69 | MP0009840_abnormal_foam_cell | 0.93051100 |
| 70 | MP0004510_myositis | 0.92058885 |
| 71 | MP0004883_abnormal_blood_vessel | 0.88797315 |
| 72 | MP0000427_abnormal_hair_cycle | 0.88533844 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.87345578 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 0.86603570 |
| 75 | MP0001968_abnormal_touch/_nociception | 0.85019829 |
| 76 | MP0000343_altered_response_to | 0.84702637 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.83647700 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.82263040 |
| 79 | MP0001545_abnormal_hematopoietic_system | 0.80773953 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 0.80773953 |
| 81 | MP0005266_abnormal_metabolism | 0.78170603 |
| 82 | MP0005451_abnormal_body_composition | 0.77340374 |
| 83 | MP0001188_hyperpigmentation | 0.74562221 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.73335078 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.73261067 |
| 86 | MP0005164_abnormal_response_to | 0.72484152 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.71532562 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.69547819 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.68950347 |
| 90 | MP0004130_abnormal_muscle_cell | 0.68691461 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 0.67965009 |
| 92 | MP0000516_abnormal_urinary_system | 0.67965009 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.67073775 |
| 94 | MP0003646_muscle_fatigue | 0.66124701 |
| 95 | MP0003091_abnormal_cell_migration | 0.66091119 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.65876918 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.65803786 |
| 98 | MP0000383_abnormal_hair_follicle | 0.64010471 |
| 99 | MP0001851_eye_inflammation | 0.63771822 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.63321876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.12824681 |
| 2 | Abnormality of T cell number (HP:0011839) | 4.84003825 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.14670344 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.12519230 |
| 5 | Optic neuritis (HP:0100653) | 4.12519230 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 3.83583268 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.81650517 |
| 8 | Orchitis (HP:0100796) | 3.62964123 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 3.56775642 |
| 10 | Thyroiditis (HP:0100646) | 3.55087241 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.50899271 |
| 12 | Stomatitis (HP:0010280) | 3.47528697 |
| 13 | Myositis (HP:0100614) | 3.41569807 |
| 14 | Hypoproteinemia (HP:0003075) | 3.39355538 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.38783471 |
| 16 | Increased IgM level (HP:0003496) | 3.35070593 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.31293737 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.25597545 |
| 19 | Abnormality of eosinophils (HP:0001879) | 3.23421642 |
| 20 | Prostate neoplasm (HP:0100787) | 3.14319935 |
| 21 | Pustule (HP:0200039) | 3.13138118 |
| 22 | Recurrent viral infections (HP:0004429) | 3.10169280 |
| 23 | Eosinophilia (HP:0001880) | 3.06116667 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 2.97025756 |
| 25 | Combined immunodeficiency (HP:0005387) | 2.94815590 |
| 26 | Leukocytosis (HP:0001974) | 2.93784940 |
| 27 | Abnormality of T cells (HP:0002843) | 2.90801813 |
| 28 | IgG deficiency (HP:0004315) | 2.81535505 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.79554270 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.79554270 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.79554270 |
| 32 | Recurrent skin infections (HP:0001581) | 2.69207614 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.65190807 |
| 34 | Lymphopenia (HP:0001888) | 2.61767586 |
| 35 | Facial diplegia (HP:0001349) | 2.61446385 |
| 36 | Abnormality of the columella (HP:0009929) | 2.61382878 |
| 37 | IgM deficiency (HP:0002850) | 2.49042689 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.48912335 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.47462594 |
| 40 | Abnormality of DNA repair (HP:0003254) | 2.46511238 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 2.45329181 |
| 42 | Congenital sensorineural hearing impairment (HP:0008527) | 2.41063485 |
| 43 | Neurodegeneration (HP:0002180) | 2.39388869 |
| 44 | Granulocytopenia (HP:0001913) | 2.38981043 |
| 45 | Submucous cleft hard palate (HP:0000176) | 2.38138507 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.36118381 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35493517 |
| 48 | IgA deficiency (HP:0002720) | 2.32485029 |
| 49 | Neonatal respiratory distress (HP:0002643) | 2.31397444 |
| 50 | B lymphocytopenia (HP:0010976) | 2.30700477 |
| 51 | Thick nail (HP:0001805) | 2.30657200 |
| 52 | Prominent nose (HP:0000448) | 2.27599474 |
| 53 | Mesangial abnormality (HP:0001966) | 2.27449792 |
| 54 | Keratoconjunctivitis (HP:0001096) | 2.26633195 |
| 55 | Basal ganglia calcification (HP:0002135) | 2.24030240 |
| 56 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.21461878 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.20053913 |
| 58 | Vasculitis (HP:0002633) | 2.16357189 |
| 59 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15763825 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15763825 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.15679318 |
| 62 | Cone-rod dystrophy (HP:0000548) | 2.15059091 |
| 63 | Periodontitis (HP:0000704) | 2.14225310 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.13682489 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09249658 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.09162583 |
| 67 | Reduced antithrombin III activity (HP:0001976) | 2.07242165 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05737415 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05737415 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05737415 |
| 71 | Disinhibition (HP:0000734) | 2.05240192 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.04264433 |
| 73 | Encephalitis (HP:0002383) | 2.03630270 |
| 74 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.00786916 |
| 75 | Keratitis (HP:0000491) | 1.98809677 |
| 76 | Anorexia (HP:0002039) | 1.97225900 |
| 77 | Hemoptysis (HP:0002105) | 1.96695786 |
| 78 | Arterial thrombosis (HP:0004420) | 1.95784794 |
| 79 | Loss of speech (HP:0002371) | 1.91238993 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.86550037 |
| 81 | Abnormality of the basal ganglia (HP:0002134) | 1.83929424 |
| 82 | Gingival bleeding (HP:0000225) | 1.82015383 |
| 83 | Tubular atrophy (HP:0000092) | 1.81878154 |
| 84 | Abnormality of the prostate (HP:0008775) | 1.81020597 |
| 85 | Papilledema (HP:0001085) | 1.80854746 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80001039 |
| 87 | Mucopolysacchariduria (HP:0008155) | 1.80001039 |
| 88 | Albinism (HP:0001022) | 1.79747255 |
| 89 | Gingivitis (HP:0000230) | 1.79161891 |
| 90 | Urticaria (HP:0001025) | 1.78856916 |
| 91 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76804671 |
| 92 | Global brain atrophy (HP:0002283) | 1.75008988 |
| 93 | Chronic diarrhea (HP:0002028) | 1.74009393 |
| 94 | Abnormality of the pleura (HP:0002103) | 1.73018694 |
| 95 | Cellular immunodeficiency (HP:0005374) | 1.72467598 |
| 96 | Vertigo (HP:0002321) | 1.70958721 |
| 97 | Decreased central vision (HP:0007663) | 1.69227421 |
| 98 | Hypoalbuminemia (HP:0003073) | 1.68331762 |
| 99 | Abnormal albumin level (HP:0012116) | 1.68331762 |
| 100 | Lymphoma (HP:0002665) | 1.68324899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.68116311 |
| 2 | MAP4K1 | 4.57245919 |
| 3 | MARK3 | 2.87408051 |
| 4 | TNIK | 2.64883868 |
| 5 | BLK | 2.42674401 |
| 6 | AKT3 | 2.38399445 |
| 7 | TXK | 2.29913856 |
| 8 | PIM2 | 2.29265479 |
| 9 | IKBKE | 2.22168903 |
| 10 | WNK3 | 2.15306128 |
| 11 | PAK3 | 2.15038021 |
| 12 | EIF2AK3 | 2.11481075 |
| 13 | PIK3CA | 2.02457977 |
| 14 | RIPK1 | 1.93715821 |
| 15 | IKBKB | 1.84471482 |
| 16 | CSK | 1.72198532 |
| 17 | MAP3K14 | 1.71171619 |
| 18 | SIK2 | 1.67821608 |
| 19 | ZAP70 | 1.60903438 |
| 20 | GRK7 | 1.60039049 |
| 21 | IRAK4 | 1.58924106 |
| 22 | TAF1 | 1.54670005 |
| 23 | NLK | 1.53218912 |
| 24 | PDK2 | 1.51822235 |
| 25 | MAPKAPK3 | 1.50516172 |
| 26 | ADRBK2 | 1.45176226 |
| 27 | STK10 | 1.39929311 |
| 28 | TAOK1 | 1.39777914 |
| 29 | FER | 1.36387973 |
| 30 | SYK | 1.31189964 |
| 31 | BMPR1B | 1.23970165 |
| 32 | CAMK1D | 1.20480407 |
| 33 | PBK | 1.17005804 |
| 34 | PLK2 | 1.16876349 |
| 35 | TLK1 | 1.15534654 |
| 36 | BTK | 1.14682612 |
| 37 | TYK2 | 1.14463575 |
| 38 | NUAK1 | 1.11110836 |
| 39 | KDR | 1.07907547 |
| 40 | IRAK3 | 1.07196215 |
| 41 | PRKCQ | 1.01130775 |
| 42 | NEK2 | 1.00610931 |
| 43 | TGFBR2 | 0.99815837 |
| 44 | FGR | 0.99553055 |
| 45 | KIT | 0.98783046 |
| 46 | EPHB1 | 0.95878033 |
| 47 | JAK1 | 0.95755549 |
| 48 | JAK3 | 0.91444366 |
| 49 | ERBB4 | 0.89547279 |
| 50 | PRKCI | 0.87595674 |
| 51 | CHUK | 0.85902919 |
| 52 | TBK1 | 0.85844264 |
| 53 | MST1R | 0.85559366 |
| 54 | HCK | 0.85134341 |
| 55 | CAMKK2 | 0.84224349 |
| 56 | ZAK | 0.83026496 |
| 57 | PIM1 | 0.82777161 |
| 58 | LCK | 0.82508098 |
| 59 | MAPK11 | 0.82353293 |
| 60 | ACVR1B | 0.81300067 |
| 61 | SGK2 | 0.80525518 |
| 62 | IRAK1 | 0.80458598 |
| 63 | CSF1R | 0.76910777 |
| 64 | PTK2B | 0.76783053 |
| 65 | STK4 | 0.75906010 |
| 66 | ITK | 0.74281499 |
| 67 | MAP3K3 | 0.73200549 |
| 68 | MATK | 0.70951843 |
| 69 | LYN | 0.65248905 |
| 70 | JAK2 | 0.59906430 |
| 71 | MAP2K3 | 0.59846727 |
| 72 | PAK1 | 0.59583649 |
| 73 | TNK2 | 0.59577108 |
| 74 | ABL1 | 0.56640980 |
| 75 | TEC | 0.56457330 |
| 76 | CAMK1G | 0.50901379 |
| 77 | OXSR1 | 0.50813294 |
| 78 | MAPKAPK5 | 0.49256352 |
| 79 | FES | 0.48894126 |
| 80 | INSRR | 0.48583953 |
| 81 | CDC42BPA | 0.47222922 |
| 82 | IGF1R | 0.47066679 |
| 83 | MAP3K5 | 0.45129484 |
| 84 | MELK | 0.42569192 |
| 85 | STK39 | 0.42201722 |
| 86 | PDGFRB | 0.41703167 |
| 87 | EGFR | 0.41085789 |
| 88 | RPS6KA5 | 0.40127090 |
| 89 | CSNK1A1L | 0.37730251 |
| 90 | IRAK2 | 0.35802319 |
| 91 | INSR | 0.35505497 |
| 92 | TRPM7 | 0.35409476 |
| 93 | PRKD1 | 0.35033186 |
| 94 | MKNK1 | 0.33658334 |
| 95 | CSNK1D | 0.32643060 |
| 96 | FLT3 | 0.32218933 |
| 97 | NEK6 | 0.31564430 |
| 98 | PDK1 | 0.31257841 |
| 99 | SGK3 | 0.30991979 |
| 100 | SGK223 | 0.30798257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.51850225 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.95035253 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.87087863 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.42567327 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.41853125 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.36513779 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.33135812 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.32570179 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.29177919 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28148647 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.19157111 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.14815242 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14541657 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09915704 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.03233843 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02837418 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94082473 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.90070985 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.88420565 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82907814 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.72205932 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70259543 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58065661 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57410165 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.53849415 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.50741905 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47329336 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44860665 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41951459 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41338812 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.38993666 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.37542400 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37523327 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.35336282 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.33675937 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.32980197 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.31555166 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26589826 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.23211285 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17601205 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15675334 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13106620 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10842385 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.09436046 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07629798 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03113286 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00556634 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99037742 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96620727 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96213075 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.90144797 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89904707 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85971137 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84214840 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83114798 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81447374 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81222996 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.77019783 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76625588 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.75831114 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75611991 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70125039 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68235212 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66305491 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61994689 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59814329 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59370856 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58593493 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53114248 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.51021073 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49492140 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48696496 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47476746 |
| 74 | RNA polymerase_Homo sapiens_hsa03020 | 0.46428767 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.44880653 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41897368 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39270144 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34797817 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34655683 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34325732 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32636323 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32074124 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30211423 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29155762 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27900957 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.26139146 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25870558 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22977796 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22479589 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.22130738 |
| 91 | RNA degradation_Homo sapiens_hsa03018 | 0.21655632 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21191544 |
| 93 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.20635666 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.19633475 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18965014 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18040152 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.17632162 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16456496 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.16045246 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15293282 |

